Developer docs
API playgroundTry for free, no card

Search company profiles

Gynoveda

Full company profile

uuid0000yve

Namestring
Gynoveda
Legal namestring
Gynoveda Femtech Private Limited
Websiteurl
gynoveda.com
Company typeenum
Private
Founded yearint
2019
Descriptiontext

Gynoveda Femtech Private Limited, founded in 2019 in Mumbai by Vishal Gupta and Rachana Gupta, is an Indian women's-health company that combines Ayurvedic proprietary medicines with technology, content, and community to address fertility, PCOS/PCOD, menstrual disorders, menopause, and male-factor infertility. Its core product line consists of FDA (Ayurveda)-certified proprietary tablet formulations (e.g., Jeehv for fertility, Myrha/Vamha for PCOS, Tula for irregular periods, Veera for heavy flow, Soma for white discharge, plus menopause tablets) sold direct-to-consumer at price points of ₹1,050–₹2,400 per product. The company runs a 4-step treatment protocol comprising a 40-minute doctor consultation covering 75+ health checks, customized Ayurvedic tablets, a Gynoveda diet plan, and ongoing follow-ups, supported by online fertility/period self-assessment tools.

Distribution is hybrid: a D2C e-commerce storefront (shop.gynoveda.com) with pan-India home delivery is paired with 50+ physical Ayurvedic fertility clinics across India staffed by 100+ doctors, supplemented by telemedicine consultations and call-center-based booking and follow-up. The company's go-to-market leans heavily on community-led acquisition through the Circle of Sisterhood Facebook group (1.2Lakh+ members), paid social on Facebook and Instagram, SEO/content marketing, and a brand ambassadorship with Bollywood actress Taapsee Pannu since 2023. The company has cumulatively served 6L+ (600,000+) customers, claims 20,000+ babies born naturally through its protocols, and cites clinical-outcome data including an 85% on-time ovulation rate in a 2023 EJPMR-published study. Funding to date totals approximately $11M ($1M seed in 2019 and $10M Series A in March 2023 led by India Alternatives Fund).

Short descriptiontext

Gynoveda is an Indian FemTech company that sells FDA-certified Ayurvedic proprietary medicines and runs a 50+ clinic network to treat fertility, PCOS, menstrual disorders, and menopause for individual consumers across India via D2C e-commerce and physical clinics.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
251–500
akta.pro rankint
HeadquartersMumbai, India
HQ citystring
Mumbai
HQ countrystring
India
HQ regionstring
Asia
Markets served

Serves global market

Offices9 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
ayurvedic medicines, women's health products, fertility treatments, menstrual health solutions, d2c healthcare
Industry3 codes
PRIMARYHLAFAJAA
Obstetrics & Gynecology (OB/GYN) Clinics
Healthcare & Life Sciences/Healthcare Providers & Systems/Women’s & Children’s Health Providers
SECONDARYCRABAIAK
Fertility & Ovulation Products (OTC)
SECONDARYHLALAHAA
Fertility & Reproductive Endocrinology Telehealth (IVF/IUI, infertility evaluation)
Healthcare & Life Sciences/Telehealth Platforms/Women’s & Family Health Telehealth Platforms (fertility, pregnancy, pediatrics)
NAICS code2 codes
  • Offices of Physicians6211
  • Family Planning Centers621410
SIC code2 codes
  • Services-Offices & Clinics Of Doctors Of Medicine8011
  • Biological Products, (No Disgnostic Substances)2836
Product category
Women's Healthcare Services
Social media profiles2 records
GTM motion3 records

Each record includes

Type, Description, Source

Revenue model3 records
1Ayurvedic Medicine Sales
TypeOne Time License
Description

Direct-to-consumer sales of proprietary Ayurvedic tablets and supplements for fertility, PCOS, menstrual health, and menopause. Products are sold through the e-commerce website (shop.gynoveda.com) with home delivery across India. Individual product purchases ranging from ₹1,050 to ₹2,400.

gynoveda.com
2Clinic Consultation Services
TypeProfessional Services
Description

Revenue from in-person and telemedicine doctor consultations at Gynoveda's network of 50+ clinics. Consultation fee is ₹2,000 which includes Ayurvedic assessment of 50+ health parameters, root cause analysis, diet suggestions, and personalized treatment guidance.

gynoveda.com
3Subscription/Repeat Purchases
TypeSubscription Recurring
Description

Customers following multi-month treatment protocols (commonly 6-12 months) make repeat purchases of Ayurvedic medicines, creating recurring revenue from established patient relationships.

gynoveda.com
Marketing channels8 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels4 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Marketing or Sales, Operations, Personnel, Supply Chain, Technology or R&D, Infrastructure
Pricing details2 tiers
1Clinic Consultation - ₹2,000
ModelUnit PricingBilling cadencePay-as-you-go
Notes

₹2,000 consultation fee includes Ayurvedic assessment of 50+ health parameters, root cause analysis, diet suggestions, and personalized treatment guidance. Open 10 AM - 8 PM, Tuesday to Sunday.

gynoveda.com
2Fertility Support Products - ₹1,400 to ₹2,400
ModelUnit PricingBilling cadencePay-as-you-go
Notes

Fertility Support Ovulation for Pregnancy: ₹2,063 (4.8 rating). PCOS/PCOD products: ₹2,400 (4.6 rating). Delayed Periods/Iregular Flow: ₹1,400 (4.8 rating). Menopause tablets: ₹1,050 (4.6 rating). Prices in INR.

gynoveda.com
GTM typeB2C
B2C
Offering typeServices
Services
Core offering1 text field

Gynoveda develops and sells proprietary FDA-certified Ayurvedic medicines for fertility, PCOS/PCOD, menstrual disorders, and menopause, paired with doctor consultations (40-minute sessions covering 75+ health checks). Products and consultations are delivered through a D2C e-commerce store (shop.gynoveda.com) with home delivery, a network of 50+ physical Ayurvedic fertility clinics across India, and telemedicine consultations.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 7 values shown
  • 85% of women ovulated on time after Gynoveda treatment per clinical study published in European Journal of Pharmaceutical and Medical Research (EJPMR), 2023
+6 more records
Product overview1 text field

Gynoveda offers an integrated Ayurvedic women's healthcare platform combining proprietary Ayurvedic medicines with fertility clinics and digital tools. The core product portfolio includes named Ayurvedic tablet formulations (Jeehv, Myrha, Vamha, Tula, Veera, Soma) targeting fertility, PCOS, menstrual disorders, and menopause. Services are delivered through 50+ physical clinics across India and online consultations, supplemented by diet guidance, fertility/period tests, and the Circle of Sisterhood community. The treatment protocol follows a 4-step process: doctor consultation, Ayurvedic tablets, Gynoveda diet, and regular follow-up care.

Product and service9 records
1Fertility Support / Ovulation for Pregnancy (Jeehv)
CategoryAyurvedic fertility medicine
Description

Ayurvedic tablets designed to improve egg quality and support healthy pregnancy; used by women/couples as part of Gynoveda's 4-step fertility treatment protocol.

2PCOS / PCOD Treatment Tablets
CategoryAyurvedic reproductive health medicine
Description

Ayurvedic proprietary medicines formulated to reverse PCOS/PCOD and regulate monthly cycles, addressing 20+ gynecological disorders in women.

3Tula for Irregular Periods
CategoryAyurvedic menstrual health medicine
Description

Ayurvedic tablets for delayed periods and lighter menstrual flow, helping women regulate their monthly cycles.

4Veera for Heavy Flow
CategoryAyurvedic menstrual health medicine
Description

Ayurvedic tablets to regulate early periods and control heavy menstrual flow.

5Soma for White Discharge and Intimate Itching
CategoryAyurvedic intimate health medicine
Description

Ayurvedic tablets for treating intimate itching and white discharge issues in women.

6Ayurvedic Menopause Tablets
CategoryAyurvedic menopause care
Description

Ayurvedic formulation to smooth menopause transition, manage weight gain, and reduce hot flashes for women approaching or experiencing menopause.

7Myrha and Vamha
CategoryAyurvedic reproductive health medicine
Description

Combination Ayurvedic medicines used to regulate menstrual cycles and treat PCOS symptoms.

8Gynoveda Fertility Clinic Consultations
CategoryHealthcare consultation service
Description

In-person and online doctor-led Ayurvedic fertility consultations lasting 40 minutes and covering 75+ health checks, delivered across 50+ Gynoveda clinics and via telemedicine, producing personalized treatment plans with Ayurvedic tablets and diet guidance.

9Gynovedic Diet
CategoryDiet and lifestyle program
Description

Personalized Ayurvedic diet and lifestyle program offered alongside Gynoveda's medicines to accelerate treatment results and support healthy pregnancy outcomes.

Scale indicator9 records

Each record includes

Type, Value, Description, Source

Recent move7 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Indian D2C women's health brand focused on menstrual hygiene, intimate care, and wellness products sold online. Most directly comparable as an Indian D2C femcare platform building category leadership with similar brand-led, content-and-community growth tactics.

2&Me (Anwin Investments)
TypeDirect peer
Description

Indian women's nutrition and wellness D2C brand selling supplements targeting PCOS, periods, fertility, and hormonal health. Closely comparable in product category (OTC supplements for female reproductive and hormonal health) and D2C go-to-market motion in India.

TypeDirect peer
Description

Indian D2C femcare brand selling toilets-to-feminine hygiene and women's wellness products through e-commerce and offline retail. Comparable as one of India's first scaled women's health D2C brands with overlapping target customers and omnichannel distribution.

TypeDirect peer
Description

Indian women's wellness D2C brand offering personalized health packs for periods, PCOS, and intimate care. Direct peer in personalized, science-meets-wellness positioning for Indian women across menstrual and hormonal concerns.

TypeEmerging player
Description

Indian FemTech brand focused on natural and Ayurvedic solutions for fertility, PCOS, and menstrual health. Highly comparable in Ayurvedic product positioning and DTC women's health focus, though smaller in scale and clinic footprint.

TypeEmerging player
Description

Indian D2C feminine care and wellness brand offering intimate hygiene, menstrual, and pregnancy care products. Comparable in D2C women's health with a community-and-content-led growth approach targeting similar Indian female audiences.

TypeEmerging player
Description

Indian D2C brand selling premium menstrual wellness products including pads and intimate care. Comparable as an emerging Indian FemTech brand focused on menstrual and intimate wellness through owned e-commerce and content.

TypeBroad incumbent
Description

Largest Indian telehealth and doctor-discovery platform offering online consultations across specialties including gynecology and fertility. Relevant as a broader incumbent telemedicine incumbent whose online consultation model overlaps with Gynoveda's telemedicine channel.

TypeBroad incumbent
Description

India's largest Ayurvedic FMCG and wellness products company spanning foods, supplements, and Ayurvedic medicines. Relevant as a broad incumbent in the Ayurvedic products space that competes for the same consumer wallet on herbal wellness positioning.

TypeBroad incumbent
Description

India's largest chain of IVF and fertility clinics offering IVF, IUI, and other assisted reproductive technology services. Relevant as a broad-incumbent fertility-treatment alternative - Gynoveda explicitly positions against this ₹3-5 lakh IVF alternative with its Ayurveda-led approach.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers6 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment6 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile5 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature3 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles3 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance2 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds2 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors7 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Gynoveda

Women's Healthcare Servicesgynoveda.com

Gynoveda is an Indian FemTech company that sells FDA-certified Ayurvedic proprietary medicines and runs a 50+ clinic network to treat fertility, PCOS, menstrual disorders, and menopause for individual consumers across India via D2C e-commerce and physical clinics.

What Gynoveda does

Gynoveda Femtech Private Limited, founded in 2019 in Mumbai by Vishal Gupta and Rachana Gupta, is an Indian women's-health company that combines Ayurvedic proprietary medicines with technology, content, and community to address fertility, PCOS/PCOD, menstrual disorders, menopause, and male-factor infertility. Its core product line consists of FDA (Ayurveda)-certified proprietary tablet formulations (e.g., Jeehv for fertility, Myrha/Vamha for PCOS, Tula for irregular periods, Veera for heavy flow, Soma for white discharge, plus menopause tablets) sold direct-to-consumer at price points of ₹1,050–₹2,400 per product. The company runs a 4-step treatment protocol comprising a 40-minute doctor consultation covering 75+ health checks, customized Ayurvedic tablets, a Gynoveda diet plan, and ongoing follow-ups, supported by online fertility/period self-assessment tools.

Distribution is hybrid: a D2C e-commerce storefront (shop.gynoveda.com) with pan-India home delivery is paired with 50+ physical Ayurvedic fertility clinics across India staffed by 100+ doctors, supplemented by telemedicine consultations and call-center-based booking and follow-up. The company's go-to-market leans heavily on community-led acquisition through the Circle of Sisterhood Facebook group (1.2Lakh+ members), paid social on Facebook and Instagram, SEO/content marketing, and a brand ambassadorship with Bollywood actress Taapsee Pannu since 2023. The company has cumulatively served 6L+ (600,000+) customers, claims 20,000+ babies born naturally through its protocols, and cites clinical-outcome data including an 85% on-time ovulation rate in a 2023 EJPMR-published study. Funding to date totals approximately $11M ($1M seed in 2019 and $10M Series A in March 2023 led by India Alternatives Fund).

Gynoveda firmographics

Firmographics
Name
Gynoveda
Legal name
Gynoveda Femtech Private Limited
Website
https://gynoveda.com
Company type
Private
Founded year
2019
Operating status
Operating
Headcount range
251–500 employees
Short description
Gynoveda is an Indian FemTech company that sells FDA-certified Ayurvedic proprietary medicines and runs a 50+ clinic network to treat fertility, PCOS, menstrual disorders, and menopause for individual consumers across India via D2C e-commerce and physical clinics.
Ownership category
akta.pro rank

Gynoveda industry classification

Industry
Product category
Women's Healthcare Services
NAICS
Offices of Physicians (6211), Family Planning Centers (621410)
SIC
Services-Offices & Clinics Of Doctors Of Medicine (8011), Biological Products, (No Disgnostic Substances) (2836)
akta.pro industry
PRIMARYHLAFAJAA
Obstetrics & Gynecology (OB/GYN) Clinics
Healthcare & Life Sciences/Healthcare Providers & Systems/Women’s & Children’s Health Providers
SECONDARYCRABAIAK
Fertility & Ovulation Products (OTC)
SECONDARYHLALAHAA
Fertility & Reproductive Endocrinology Telehealth (IVF/IUI, infertility evaluation)
Healthcare & Life Sciences/Telehealth Platforms/Women’s & Family Health Telehealth Platforms (fertility, pregnancy, pediatrics)

Keywords

  • Ayurvedic medicines
  • Women's health products
  • Fertility treatments
  • Menstrual health solutions
  • D2c healthcare

Where Gynoveda is headquartered

Location

Headquarters

HQ city
Mumbai
HQ country
India
HQ region
Asia

Offices9 records

Markets served

Gynoveda business model

Business model
GTM type
B2C
Offering type
Services
Cost components
Marketing or Sales, Operations, Personnel, Supply Chain, Technology or R&D, Infrastructure

Revenue model

  1. Ayurvedic Medicine Sales: Direct-to-consumer sales of proprietary Ayurvedic tablets and supplements for fertility, PCOS, menstrual health, and menopause. Products are sold through the e-commerce website (shop.gynoveda.com) with home delivery across India. Individual product purchases ranging from ₹1,050 to ₹2,400.
  2. Clinic Consultation Services: Revenue from in-person and telemedicine doctor consultations at Gynoveda's network of 50+ clinics. Consultation fee is ₹2,000 which includes Ayurvedic assessment of 50+ health parameters, root cause analysis, diet suggestions, and personalized treatment guidance.
  3. Subscription/Repeat Purchases: Customers following multi-month treatment protocols (commonly 6-12 months) make repeat purchases of Ayurvedic medicines, creating recurring revenue from established patient relationships.

Pricing tiers

ModelBillingPrice
Unit PricingPay-as-you-goClinic Consultation - ₹2,000
Unit PricingPay-as-you-goFertility Support Products - ₹1,400 to ₹2,400

Go-to-market motion3 records

Distribution channels4 records

Marketing channels8 records

Gynoveda product offering

Product offering

Core offering

Gynoveda develops and sells proprietary FDA-certified Ayurvedic medicines for fertility, PCOS/PCOD, menstrual disorders, and menopause, paired with doctor consultations (40-minute sessions covering 75+ health checks). Products and consultations are delivered through a D2C e-commerce store (shop.gynoveda.com) with home delivery, a network of 50+ physical Ayurvedic fertility clinics across India, and telemedicine consultations.

Product overview

Gynoveda offers an integrated Ayurvedic women's healthcare platform combining proprietary Ayurvedic medicines with fertility clinics and digital tools. The core product portfolio includes named Ayurvedic tablet formulations (Jeehv, Myrha, Vamha, Tula, Veera, Soma) targeting fertility, PCOS, menstrual disorders, and menopause. Services are delivered through 50+ physical clinics across India and online consultations, supplemented by diet guidance, fertility/period tests, and the Circle of Sisterhood community. The treatment protocol follows a 4-step process: doctor consultation, Ayurvedic tablets, Gynoveda diet, and regular follow-up care.

Differentiator

Problem solved

Functional benefit

Products and services

  • Fertility Support / Ovulation for Pregnancy (Jeehv) Ayurvedic tablets designed to improve egg quality and support healthy pregnancy; used by women/couples as part of Gynoveda's 4-step fertility treatment protocol.
  • PCOS / PCOD Treatment Tablets Ayurvedic proprietary medicines formulated to reverse PCOS/PCOD and regulate monthly cycles, addressing 20+ gynecological disorders in women.
  • Tula for Irregular Periods Ayurvedic tablets for delayed periods and lighter menstrual flow, helping women regulate their monthly cycles.
  • Veera for Heavy Flow Ayurvedic tablets to regulate early periods and control heavy menstrual flow.
  • Soma for White Discharge and Intimate Itching Ayurvedic tablets for treating intimate itching and white discharge issues in women.
  • Ayurvedic Menopause Tablets Ayurvedic formulation to smooth menopause transition, manage weight gain, and reduce hot flashes for women approaching or experiencing menopause.
  • Myrha and Vamha Combination Ayurvedic medicines used to regulate menstrual cycles and treat PCOS symptoms.
  • Gynoveda Fertility Clinic Consultations In-person and online doctor-led Ayurvedic fertility consultations lasting 40 minutes and covering 75+ health checks, delivered across 50+ Gynoveda clinics and via telemedicine, producing personalized treatment plans with Ayurvedic tablets and diet guidance.
  • Gynovedic Diet Personalized Ayurvedic diet and lifestyle program offered alongside Gynoveda's medicines to accelerate treatment results and support healthy pregnancy outcomes.

Quantifiable outcome

  • 85% of women ovulated on time after Gynoveda treatment per clinical study published in European Journal of Pharmaceutical and Medical Research (EJPMR), 2023
  • +6 more outcomes

Companies that use Gynoveda

Customer profile

Named customers6 records

Segments6 records

Ideal customer profiles5 records

Gynoveda technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature3 records

Gynoveda partnerships and signals

Strategic signal

Scale indicators9 records

Recent moves7 records

Expansion highlights6 records

Gynoveda competitors and assessment

Company assessment

Direct peers

  • Sirona Hygiene: Indian D2C women's health brand focused on menstrual hygiene, intimate care, and wellness products sold online. Most directly comparable as an Indian D2C femcare platform building category leadership with similar brand-led, content-and-community growth tactics.
  • &Me (Anwin Investments): Indian women's nutrition and wellness D2C brand selling supplements targeting PCOS, periods, fertility, and hormonal health. Closely comparable in product category (OTC supplements for female reproductive and hormonal health) and D2C go-to-market motion in India.
  • Pee Safe: Indian D2C femcare brand selling toilets-to-feminine hygiene and women's wellness products through e-commerce and offline retail. Comparable as one of India's first scaled women's health D2C brands with overlapping target customers and omnichannel distribution.
  • Nua (Nua Woman): Indian women's wellness D2C brand offering personalized health packs for periods, PCOS, and intimate care. Direct peer in personalized, science-meets-wellness positioning for Indian women across menstrual and hormonal concerns.

Emerging players

  • Veeda (formerly iCareBetter): Indian FemTech brand focused on natural and Ayurvedic solutions for fertility, PCOS, and menstrual health. Highly comparable in Ayurvedic product positioning and DTC women's health focus, though smaller in scale and clinic footprint.
  • Avni (Conscious Chemist): Indian D2C feminine care and wellness brand offering intimate hygiene, menstrual, and pregnancy care products. Comparable in D2C women's health with a community-and-content-led growth approach targeting similar Indian female audiences.
  • Carmesi: Indian D2C brand selling premium menstrual wellness products including pads and intimate care. Comparable as an emerging Indian FemTech brand focused on menstrual and intimate wellness through owned e-commerce and content.

Broad incumbents

  • Practo: Largest Indian telehealth and doctor-discovery platform offering online consultations across specialties including gynecology and fertility. Relevant as a broader incumbent telemedicine incumbent whose online consultation model overlaps with Gynoveda's telemedicine channel.
  • Patanjali Ayurved: India's largest Ayurvedic FMCG and wellness products company spanning foods, supplements, and Ayurvedic medicines. Relevant as a broad incumbent in the Ayurvedic products space that competes for the same consumer wallet on herbal wellness positioning.
  • Nova IVF Fertility: India's largest chain of IVF and fertility clinics offering IVF, IUI, and other assisted reproductive technology services. Relevant as a broad-incumbent fertility-treatment alternative - Gynoveda explicitly positions against this ₹3-5 lakh IVF alternative with its Ayurveda-led approach.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

Gynoveda social profiles

Digital presence

Gynoveda compliance and trust

Trust signal

Compliance2 records

Gynoveda financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Gynoveda leadership team

Management profile

Number of profiles

Profiles3 records

Gynoveda funding detail

Funding detail

Funding overview

Funding rounds2 records

Investors7 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Gynoveda M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Gynoveda

What does Gynoveda do?

Gynoveda develops and sells proprietary FDA-certified Ayurvedic medicines for fertility, PCOS/PCOD, menstrual disorders, and menopause, paired with doctor consultations (40-minute sessions covering 75+ health checks). Products and consultations are delivered through a D2C e-commerce store (shop.gynoveda.com) with home delivery, a network of 50+ physical Ayurvedic fertility clinics across India, and telemedicine consultations.

Is Gynoveda a public or private company?

Gynoveda is a private company. It is classified as venture growth investor backed and is currently operating.

When was Gynoveda founded?

Gynoveda was founded in 2019. It employs 251 to 500 people.

Where is Gynoveda based?

Gynoveda is headquartered in Mumbai, India, in the Asia region.

How does Gynoveda make money?

Three revenue lines are on record. Ayurvedic Medicine Sales are the primary driver. The others are clinic Consultation Services and subscription/Repeat Purchases.

Who are Gynoveda's main competitors?

Direct peers on record are Sirona Hygiene, &Me (Anwin Investments), Pee Safe and Nua (Nua Woman). Emerging players are Veeda (formerly iCareBetter), Avni (Conscious Chemist) and Carmesi. Broad incumbents are Practo, Patanjali Ayurved and Nova IVF Fertility.

Does Gynoveda have an API?

No public API is recorded for Gynoveda.

What industry is Gynoveda in?

Gynoveda's product category is Women's Healthcare Services. Its primary akta.pro industry code is HLAFAJAA, Obstetrics & Gynecology (OB/GYN) Clinics, with a secondary code of CRABAIAK, Fertility & Ovulation Products (OTC). Its NAICS code is 6211 and its SIC code is 8011.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
The Times of IndiaGame on: Women show that authenticity is the new ambitionAuthor Kiran Manral released her new book, 'The Gamechangers: Women Entrepreneurs Redefining Success', which profiles women entrepreneurs in India who are redefining leadership through authenticity and purpose rather than traditional hustle culture. The book highlights specific business figures such as Vineeta Singh of Sugar Cosmetics and Rachana Gupta of Gynoveda, emphasizing their resilience and empathetic leadership styles.Infomance8 Ayurvedic Startups Of India Blending Ancient Wisdom With Modern BusinessThe article profiles eight Ayurvedic startups in India, highlighting their market valuations, product offerings, and strategic developments such as acquisitions and regulatory challenges. Key events include Hindustan Unilever's acquisition of OZiva, Patanjali Foods' approval to acquire the Home and Personal Care business from Patanjali Ayurved Limited, and Gynoveda facing an FDA raid for misleading packaging claims.BusinessLineWipro Consumer Care-Ventures invests in women’s healthtech company GynovedaWipro Consumer Care-Ventures invested in women's healthtech company Gynoveda, founded in 2019 to treat infertility, PCOS, and irregular cycles. The company has improved health for 3 lakh women across 20,000 pin codes in India, selling FDA and NABL-certified formulations.IndiaWeb2Ayurveda-backed Women's Healthcare Startup Gynoveda Raises $10 Mn in Series A Funding Led by India Alternatives FundGynoveda, an Ayurveda-backed women's healthcare startup, has raised $10 million in Series A funding led by India Alternatives Fund. The company plans to deploy the capital towards strengthening R&D, expanding distribution channels, and increasing brand awareness to reach more women across India. This follows significant growth, with the company tripling its revenue year-on-year between FY20 and FY23 to reach a ₹100 crore annual run rate.EntrepreneurGynoveda Raises $10 Million In Series A Funding RoundGynoveda, an Ayurveda-backed women’s healthcare startup, has raised $10 million in a Series A funding round led by India Alternatives Fund with participation from investors including Wipro Enterprises and Fireside Ventures. The company plans to utilize the capital to strengthen R&D, expand distribution channels, and increase brand awareness for its menstrual health products. This funding follows significant growth, with Gynoveda tripling its revenue year-on-year between FY20 and FY23 to reach an annual run rate of INR 100 crores.IncubeesAyurveda D2C startup Gynoveda secured $10 M Series A funding from India Alternatives Fund – IncubeesAyurveda D2C startup Gynoveda has secured $10 million in a Series A funding round led by India Alternatives Fund, with participation from existing investor Fireside Ventures and others including Wipro Enterprises. The company intends to utilize the capital to enhance R&D, expand distribution channels, and increase brand recognition. This follows previous seed funding and coincides with reported revenue growth of 3.25X year-over-year despite increased losses.MediaBriefGynoveda raises $10mn in Series A funding led by India Alternatives Fund › Mediabrief.comGynoveda, an Ayurveda-backed women’s healthcare startup, has raised $10 million in Series A funding led by India Alternatives Fund. This funding round included participation from Wipro Enterprises, RPG Ventures, Dharampal Satyapal Ltd, and Alteria Capital, allowing Gynoveda to expand its research, product offerings, and market presence. The company aims to revolutionize women's healthcare by using Ayurveda to address complex gynecological disorders, having already improved the health of over 300,000 women across India.IndianvaidyasAyurveda D2C startup Gynoveda raises $10 Mn in a Series A roundAyurveda D2C startup Gynoveda has raised $10 million in a Series A funding round led by India Alternatives Fund, with participation from Wipro Enterprises, RPG Ventures, Dharampal Satyapal Ltd, Alteria Capital, and Fireside Ventures. The company intends to utilize the capital to strengthen research and development, expand distribution channels, and increase brand awareness.VCCircleYellow Metal, Gynoveda, others snag early-stage chequesYellow Metal, Gynoveda, BuyStars, and One Impression raised early-stage funding on Wednesday. Yellow Metal took $3M, Gynoveda $10M, BuyStars $5M, and One Impression $10M, with funds for technology, R&D, hiring, and expansion.